Benson Hill Biosystems Raises $25m Series B, Reveals CRISPR 2.0

Benson Hill Biosystems has identified a more precise and efficient gene-editing tool than CRISPR Cas-9, according to Matt Crisp, CEO.

Source: BREAKING EXCLUSIVE: Benson Hill Biosystems Raises $25m Series B, Reveals CRISPR 2.0 – AgFunderNews